Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


Articles published in Psychiatry Res

Retrieve available abstracts of 351 articles:
HTML format
Text format



Single Articles


    May 2017
  1. SCHOELER T, Petros N, Di Forti M, Klamerus E, et al
    Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis.
    Psychiatry Res. 2017;255:36-41.
    PubMed     Text format     Abstract available


  2. BOUAZIZ N, Moulier V, Lettelier-Galle T, Osmond I, et al
    Impact of reward on pain threshold and tolerance to experimental pain (Cold Pressor Task) in healthy subjects and patients with schizophrenia.
    Psychiatry Res. 2017;254:275-278.
    PubMed     Text format    


    April 2017
  3. TERACHI S, Yamada T, Pu S, Yokoyama K, et al
    Comparison of neurocognitive function in major depressive disorder, bipolar disorder, and schizophrenia in later life: A cross-sectional study of euthymic or remitted, non-demented patients using the Japanese version of the Brief Assessment of Cogniti
    Psychiatry Res. 2017;254:205-210.
    PubMed     Text format     Abstract available


  4. GARRIDO G, Penades R, Barrios M, Aragay N, et al
    Computer-assisted cognitive remediation therapy in schizophrenia: Durability of the effects and cost-utility analysis.
    Psychiatry Res. 2017;254:198-204.
    PubMed     Text format     Abstract available


  5. ISHIWATA S, Hattori K, Sasayama D, Teraishi T, et al
    Plasma and cerebrospinal fluid G72 protein levels in schizophrenia and major depressive disorder.
    Psychiatry Res. 2017;254:244-250.
    PubMed     Text format     Abstract available


  6. SHE S, Deng Y, Chen Y, Wu C, et al
    Two-stage integrated care versus antipsychotic medication alone on outcomes of schizophrenia: One-year randomized controlled trial and follow-up.
    Psychiatry Res. 2017;254:164-172.
    PubMed     Text format     Abstract available


  7. DEMPSTER K, Norman R, Theberge J, Densmore M, et al
    Cognitive performance is associated with gray matter decline in first-episode psychosis.
    Psychiatry Res. 2017;264:46-51.
    PubMed     Text format     Abstract available


  8. GUO W, Liu F, Chen J, Wu R, et al
    Using short-range and long-range functional connectivity to identify schizophrenia with a family-based case-control design.
    Psychiatry Res. 2017;264:60-67.
    PubMed     Text format     Abstract available


  9. ERTEKIN E, Ucok A, Keskin-Ergen Y, Devrim-Ucok M, et al
    Deficits in Go and NoGo P3 potentials in patients with schizophrenia.
    Psychiatry Res. 2017;254:126-132.
    PubMed     Text format     Abstract available


  10. SIMONSEN C, Faerden A, Romm KL, Berg AO, et al
    Early clinical recovery in first-episode psychosis: Symptomatic remission and its correlates at 1-year follow-up.
    Psychiatry Res. 2017;254:118-125.
    PubMed     Text format     Abstract available


  11. LI Y, Hou CL, Ma XR, Zhong BL, et al
    Quality of life in Chinese patients with schizophrenia treated in primary care.
    Psychiatry Res. 2017;254:80-84.
    PubMed     Text format     Abstract available


  12. GALLETTI C, Paolini E, Tortorella A, Compton MT, et al
    Auditory and non-auditory hallucinations in first-episode psychosis: Differential associations with diverse clinical features.
    Psychiatry Res. 2017;254:268-274.
    PubMed     Text format     Abstract available


  13. TSOTSI S, Kosmidis MH, Bozikas VP
    Improved facial affect recognition in schizophrenia following an emotion intervention, but not training attention-to-facial-features or treatment-as-usual.
    Psychiatry Res. 2017;254:135-142.
    PubMed     Text format     Abstract available


  14. DA SILVA S, Saperia S, Siddiqui I, Fervaha G, et al
    Investigating consummatory and anticipatory pleasure across motivation deficits in schizophrenia and healthy controls.
    Psychiatry Res. 2017;254:112-117.
    PubMed     Text format     Abstract available


  15. OHMURO N, Matsumoto K, Ishii Y, Katsura M, et al
    The associations between quality of life and clinical symptoms in individuals with an at-risk mental state and first-episode psychosis.
    Psychiatry Res. 2017;254:54-59.
    PubMed     Text format     Abstract available


  16. ARMANDO M, Lin A, Pontillo M, Vicari S, et al
    Prevalence and treatment of psychiatric disorders other than psychosis in children and adolescents with 22q11DS: Examining associations with social and role functioning.
    Psychiatry Res. 2017;254:238-243.
    PubMed     Text format     Abstract available


  17. FOND G, Godin O, Boyer L, Llorca PM, et al
    Advanced paternal age is associated with earlier schizophrenia onset in offspring. Results from the national multicentric FACE-SZ cohort.
    Psychiatry Res. 2017;254:218-223.
    PubMed     Text format     Abstract available


  18. LO CASCIO N, Curto M, Pasqualetti P, Lindau JF, et al
    Impairment in Social Functioning differentiates youth meeting Ultra-High Risk for psychosis criteria from other mental health help-seekers: A validation of the Italian version of the Global Functioning: Social and Global Functioning: Role scales.
    Psychiatry Res. 2017;253:296-302.
    PubMed     Text format     Abstract available


  19. COENTRE R, Talina MC, Gois C, Figueira ML, et al
    Depressive symptoms and suicidal behavior after first-episode psychosis: A comprehensive systematic review.
    Psychiatry Res. 2017;253:240-248.
    PubMed     Text format     Abstract available


  20. RAVICHANDRAN C, Shinn AK, Ongur D, Perlis RH, et al
    Frequency of non-right-handedness in bipolar disorder and schizophrenia.
    Psychiatry Res. 2017;253:267-269.
    PubMed     Text format     Abstract available


  21. BAHORIK AL, Greeno CG, Cochran G, Cornelius JR, et al
    Motivation deficits and use of alcohol and illicit drugs among individuals with schizophrenia.
    Psychiatry Res. 2017;253:391-397.
    PubMed     Text format     Abstract available


  22. BORTOLON C, Capdevielle D, Altman R, Macgregor A, et al
    Mirror self-face perception in individuals with schizophrenia: Feelings of strangeness associated with one's own image.
    Psychiatry Res. 2017;253:205-210.
    PubMed     Text format     Abstract available


    March 2017
  23. KALMADY SV, Shivakumar V, Arasappa R, Subramaniam A, et al
    Clinical correlates of hippocampus volume and shape in antipsychotic-naive schizophrenia.
    Psychiatry Res. 2017;263:93-102.
    PubMed     Text format     Abstract available


  24. WU XJ, Zeng LL, Shen H, Yuan L, et al
    Functional network connectivity alterations in schizophrenia and depression.
    Psychiatry Res. 2017;263:113-120.
    PubMed     Text format     Abstract available


  25. WANG C, Zhang Y
    Season of birth and schizophrenia: Evidence from China.
    Psychiatry Res. 2017;253:189-196.
    PubMed     Text format     Abstract available


  26. WUSTEN C, Lincoln TM
    The association of family functioning and psychosis proneness in five countries that differ in cultural values and family structures.
    Psychiatry Res. 2017;253:158-164.
    PubMed     Text format     Abstract available


  27. BOLL KM, Noto C, Bonifacio KL, Bortolasci CC, et al
    Oxidative and nitrosative stress biomarkers in chronic schizophrenia.
    Psychiatry Res. 2017;253:43-48.
    PubMed     Text format     Abstract available


  28. JAHSHAN C, Wolf M, Karbi Y, Shamir E, et al
    Probing the magnocellular and parvocellular visual pathways in facial emotion perception in schizophrenia.
    Psychiatry Res. 2017;253:38-42.
    PubMed     Text format     Abstract available


  29. FORNS-NADAL M, Berge D, Sem F, Mane A, et al
    Increased nucleus accumbens volume in first-episode psychosis.
    Psychiatry Res. 2017;263:57-60.
    PubMed     Text format     Abstract available


  30. RAFFARD S, Bortolon C, Stephan Y, Capdevielle D, et al
    Personality traits are associated with the valence of future imagined events in individuals with schizophrenia.
    Psychiatry Res. 2017;253:138-141.
    PubMed     Text format     Abstract available


  31. VANCAMPFORT D, De Hert M, Myin-Germeys I, van Winkel R, et al
    Lower cardiorespiratory fitness is associated with more time spent sedentary in first episode psychosis: A pilot study.
    Psychiatry Res. 2017;253:13-17.
    PubMed     Text format     Abstract available


  32. LUAN Z, Zhang D
    The anaplastic lymphoma kinase (ALK) gene is associated with schizophrenia in a Chinese population.
    Psychiatry Res. 2017 Mar 9. pii: S0165-1781(16)31996.
    PubMed     Text format    


  33. GROVER S, Sahoo S, Dua D, Chakrabarti S, et al
    Scales for assessment of depression in schizophrenia: Factor analysis of calgary depression rating scale and hamilton depression rating scale.
    Psychiatry Res. 2017;252:333-339.
    PubMed     Text format     Abstract available


  34. LARIVIERE S, Lavigne KM, Woodward TS, Gerretsen P, et al
    Altered functional connectivity in brain networks underlying self-referential processing in delusions of reference in schizophrenia.
    Psychiatry Res. 2017;263:32-43.
    PubMed     Text format     Abstract available


  35. BOLINSKEY PK, Smith EA, Schuder KM, Cooper-Bolinskey D, et al
    Schizophrenia spectrum personality disorders in psychometrically identified schizotypes at two-year follow-up.
    Psychiatry Res. 2017;252:289-295.
    PubMed     Text format     Abstract available


  36. YU LQ, Lee S, Katchmar N, Satterthwaite TD, et al
    Steeper discounting of delayed rewards in schizophrenia but not first-degree relatives.
    Psychiatry Res. 2017;252:303-309.
    PubMed     Text format     Abstract available


  37. CHU CS, Chow PC, Cohen-Woods S, Gaysina D, et al
    The DAOA gene is associated with schizophrenia in the Taiwanese population.
    Psychiatry Res. 2017;252:201-207.
    PubMed     Text format     Abstract available


  38. MI W, Zhang S, Liu Q, Yang F, et al
    Prevalence and risk factors of agitation in newly hospitalized schizophrenia patients in China: An observational survey.
    Psychiatry Res. 2017;253:401-406.
    PubMed     Text format     Abstract available


  39. RIBOLSI M, Lin A, Wardenaar KJ, Pontillo M, et al
    Clinical presentation of Attenuated Psychosis Syndrome in children and adolescents: Is there an age effect?
    Psychiatry Res. 2017;252:169-174.
    PubMed     Text format     Abstract available


    February 2017
  40. MASSONS C, Lopez-Morinigo JD, Pousa E, Ruiz A, et al
    Insight and suicidality in psychosis: A cross-sectional study.
    Psychiatry Res. 2017;252:147-153.
    PubMed     Text format     Abstract available


  41. BI Y, Huang X, Niu W, Chen S, et al
    No association between SLC6A2, SLC6A3, DRD2 polymorphisms and schizophrenia in the Han Chinese population.
    Psychiatry Res. 2017;253:398-400.
    PubMed     Text format     Abstract available


  42. MCCARTHY-JONES S, Smailes D, Corvin A, Gill M, et al
    Occurrence and co-occurrence of hallucinations by modality in schizophrenia-spectrum disorders.
    Psychiatry Res. 2017;252:154-160.
    PubMed     Text format     Abstract available


  43. PERRON M, Roy-Charland A, Dickinson J, LaForge C, et al
    The use of the Duchenne marker and symmetry of the expression in the judgment of smiles in schizophrenia.
    Psychiatry Res. 2017;252:126-133.
    PubMed     Text format     Abstract available


  44. FUNG CK, Moore MM, Karcher NR, Kerns JG, et al
    Emotional word usage in groups at risk for schizophrenia-spectrum disorders: An objective investigation of attention to emotion.
    Psychiatry Res. 2017;252:29-37.
    PubMed     Text format     Abstract available


  45. SHARMA A, Schray A, Bartolovic M, Roesch-Ely D, et al
    Relationship between serum calcium and neuropsychological performance might indicate etiological heterogeneity underlying cognitive deficits in schizophrenia and depression.
    Psychiatry Res. 2017;252:80-86.
    PubMed     Text format     Abstract available


  46. DUNNE PW, Roberts DL, Quinones MP, Velligan DI, et al
    Immune markers of social cognitive bias in schizophrenia.
    Psychiatry Res. 2017;251:319-324.
    PubMed     Text format     Abstract available


  47. GERRETSEN P, Pothier DD, Falls C, Armstrong M, et al
    Vestibular stimulation improves insight into illness in schizophrenia spectrum disorders.
    Psychiatry Res. 2017;251:333-341.
    PubMed     Text format     Abstract available


  48. MCKETIN R, Baker AL, Dawe S, Voce A, et al
    Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
    Psychiatry Res. 2017;251:349-354.
    PubMed     Text format     Abstract available


  49. HERNIMAN SE, Allott KA, Killackey E, Hester R, et al
    The psychometric validity of the Center for Epidemiological Studies - Depression Scale (CES-D) in first episode schizophrenia spectrum.
    Psychiatry Res. 2017;252:16-22.
    PubMed     Text format     Abstract available


  50. BECHI M, Bosia M, Spangaro M, Buonocore M, et al
    Exploring functioning in schizophrenia: Predictors of functional capacity and real-world behaviour.
    Psychiatry Res. 2017;251:118-124.
    PubMed     Text format     Abstract available


  51. DARMEDRU C, Demily C, Franck N
    Cognitive remediation and social cognitive training for violence in schizophrenia: a systematic review.
    Psychiatry Res. 2017;251:266-274.
    PubMed     Text format     Abstract available


  52. FRANCIS MM, Hummer TA, Leonhardt BL, Vohs JL, et al
    Association of medial prefrontal resting state functional connectivity and metacognitive capacity in early phase psychosis.
    Psychiatry Res. 2017;262:8-14.
    PubMed     Text format     Abstract available


  53. HU TM, Hsu SH, Tsai SM, Cheng MC, et al
    DNA methylation analysis of the EGR3 gene in patients of schizophrenia.
    Psychiatry Res. 2017;251:115-117.
    PubMed     Text format     Abstract available


  54. TOPCUOGLU C, Bakirhan A, Yilmaz FM, Neselioglu S, et al
    Thiol/disulfide homeostasis in untreated schizophrenia patients.
    Psychiatry Res. 2017;251:212-216.
    PubMed     Text format     Abstract available


  55. VAN DEN NOORT M, Perriard B, Lim S, Bosch P, et al
    Why are self-rating results in patients with schizophrenia often unreliable?
    Psychiatry Res. 2017;251:76-77.
    PubMed     Text format    


  56. MALHERBE PJ, Karayiorgou M, Ehlers R, Roos JL, et al
    Increased risk of suicide in schizophrenia patients with linkage to chromosome 13q.
    Psychiatry Res. 2017;251:34-35.
    PubMed     Text format     Abstract available


  57. SCHULTZ CC, Wagner G, Schachtzabel C, Reichenbach JR, et al
    Increased white matter radial diffusivity is associated with prefrontal cortical folding deficits in schizophrenia.
    Psychiatry Res. 2017;261:91-95.
    PubMed     Text format     Abstract available


  58. BILGI MM, Taspinar S, Aksoy B, Oguz K, et al
    The relationship between childhood trauma, emotion recognition, and irritability in schizophrenia patients.
    Psychiatry Res. 2017;251:90-96.
    PubMed     Text format     Abstract available


  59. JANSEN JE, Lysaker PH, Trauelsen AM, Luther L, et al
    Metacognitive mastery in persons with first-episode psychosis and their caregivers: Implications for timely help-seeking and caregiver experiences. Brief report.
    Psychiatry Res. 2017;251:54-57.
    PubMed     Text format     Abstract available


  60. GERRETSEN P, Takeuchi H, Ozzoude M, Graff-Guerrero A, et al
    Insight into illness and its relationship to illness severity, cognition and estimated antipsychotic dopamine receptor occupancy in schizophrenia: An antipsychotic dose reduction study.
    Psychiatry Res. 2017;251:20-25.
    PubMed     Text format     Abstract available


    January 2017
  61. STEINAU S, Stegmayer K, Lang FU, Jager M, et al
    Comparison of psychopathological dimensions between major depressive disorder and schizophrenia spectrum disorders focusing on language, affectivity and motor behavior.
    Psychiatry Res. 2017;250:169-176.
    PubMed     Text format     Abstract available


  62. OTA M, Sato N, Hidese S, Teraishi T, et al
    Structural differences in hippocampal subfields among schizophrenia patients, major depressive disorder patients, and healthy subjects.
    Psychiatry Res. 2017;259:54-59.
    PubMed     Text format     Abstract available


  63. ALTAMURA AC, Delvecchio G, Paletta S, Di Pace C, et al
    Gray matter volumes may predict the clinical response to paliperidone palmitate long-acting in acute psychosis: A pilot longitudinal neuroimaging study.
    Psychiatry Res. 2017;261:80-84.
    PubMed     Text format     Abstract available


  64. GROVER S, Dua D, Chakrabarti S, Avasthi A, et al
    Obsessive Compulsive Symptoms/disorder in patients with schizophrenia: Prevalence, relationship with other symptom dimensions and impact on functioning.
    Psychiatry Res. 2017;250:277-284.
    PubMed     Text format     Abstract available


  65. YOSHIMURA B, Yada Y, So R, Takaki M, et al
    The critical treatment window of clozapine in treatment-resistant schizophrenia: Secondary analysis of an observational study.
    Psychiatry Res. 2017;250:65-70.
    PubMed     Text format     Abstract available


  66. GORCZYNSKI P, Firth J, Stubbs B, Rosenbaum S, et al
    Are people with schizophrenia adherent to diabetes medication? A comparative meta-analysis.
    Psychiatry Res. 2017;250:17-24.
    PubMed     Text format     Abstract available


  67. TAKAHASHI S, Suzuki M, Uchiyama M, Nakayama T, et al
    Replication study of de novo mutations of TAF13 in schizophrenia.
    Psychiatry Res. 2017 Jan 21. pii: S0165-1781(16)31460.
    PubMed     Text format    


  68. HUKIC DS, Lavebratt C, Olsson E, Ostenson CG, et al
    Troponin T levels associated with genetic variants in NOTCH2 and MTNR1B in women with psychosis.
    Psychiatry Res. 2017;250:217-220.
    PubMed     Text format     Abstract available


  69. MORERA-FUMERO AL, Diaz-Mesa E, Abreu-Gonzalez P, Fernandez-Lopez L, et al
    Low levels of serum total antioxidant capacity and presence at admission and absence at discharge of a day/night change as a marker of acute paranoid schizophrenia relapse.
    Psychiatry Res. 2017;249:200-205.
    PubMed     Text format     Abstract available


  70. HELLE S, Loberg EM, Gjestad R, Schnakenberg Martin AM, et al
    The positive link between executive function and lifetime cannabis use in schizophrenia is not explained by current levels of superior social cognition.
    Psychiatry Res. 2017;250:92-98.
    PubMed     Text format     Abstract available


  71. MANE A, Berge D, Penzol MJ, Parellada M, et al
    Cannabis use, COMT, BDNF and age at first-episode psychosis.
    Psychiatry Res. 2017;250:38-43.
    PubMed     Text format     Abstract available


  72. GROVER S, Chakrabarti S, Hazari N, Avasthi A, et al
    Effectiveness of electroconvulsive therapy in patients with treatment resistant schizophrenia: A retrospective study.
    Psychiatry Res. 2017;249:349-353.
    PubMed     Text format     Abstract available


  73. JIMENEZ AM, Lee J, Green MF, Wynn JK, et al
    Functional connectivity when detecting rare visual targets in schizophrenia.
    Psychiatry Res. 2017;261:35-43.
    PubMed     Text format     Abstract available


  74. ZHOU Y, Rosenheck R, Mohamed S, Ning Y, et al
    Factors associated with complete discontinuation of medication among patients with schizophrenia in the year after hospital discharge.
    Psychiatry Res. 2017;250:129-135.
    PubMed     Text format     Abstract available


  75. GOGHARI VM
    Personality dimensions in schizophrenia: A family study.
    Psychiatry Res. 2017;251:162-167.
    PubMed     Text format     Abstract available


  76. WANG J, Liu Q, Wydell TN, Liao J, et al
    Electrophysiological basis of reading related phonological impairment in Chinese speakers with schizophrenia: An ERP study.
    Psychiatry Res. 2017;261:65-71.
    PubMed     Text format     Abstract available


  77. FONG TC, Ho RT, Wan AH, Au-Yeung FS, et al
    Psychiatric symptoms mediate the effects of neurological soft signs on functional outcomes in patients with chronic schizophrenia: A longitudinal path-analytic study.
    Psychiatry Res. 2017;249:152-158.
    PubMed     Text format     Abstract available


  78. IASEVOLI F, Fagiolini A, Formato MV, Prinzivalli E, et al
    Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patients.
    Psychiatry Res. 2017;249:159-166.
    PubMed     Text format     Abstract available


  79. KINCAID DL, Doris M, Shannon C, Mulholland C, et al
    What is the prevalence of autism spectrum disorder and ASD traits in psychosis? A systematic review.
    Psychiatry Res. 2017;250:99-105.
    PubMed     Text format     Abstract available


  80. MERRILL AM, Karcher NR, Cicero DC, Becker TM, et al
    Evidence that communication impairment in schizophrenia is associated with generalized poor task performance.
    Psychiatry Res. 2017;249:172-179.
    PubMed     Text format     Abstract available


  81. LI Z, Lei W, Deng W, Zheng Z, et al
    Aberrant spontaneous neural activity and correlation with evoked-brain potentials in first-episode, treatment-naive patients with deficit and non-deficit schizophrenia.
    Psychiatry Res. 2017;261:9-19.
    PubMed     Text format     Abstract available


  82. WEISS EM, Singewald E, Baldus C, Hofer E, et al
    Differences in psychological and somatic symptom cluster score profiles between subjects with Idiopathic environmental intolerance, major depression and schizophrenia.
    Psychiatry Res. 2017;249:187-194.
    PubMed     Text format     Abstract available


  83. DARRELL-BERRY H, Bucci S, Palmier-Claus J, Emsley R, et al
    Predictors and mediators of trait anger across the psychosis continuum: The role of attachment style, paranoia and social cognition.
    Psychiatry Res. 2017;249:132-138.
    PubMed     Text format     Abstract available


  84. ROBUSTELLI BL, Newberry RE, Whisman MA, Mittal VA, et al
    Social relationships in young adults at ultra high risk for psychosis.
    Psychiatry Res. 2017;247:345-351.
    PubMed     Text format     Abstract available


    December 2016
  85. YASUYAMA T, Ohi K, Shimada T, Uehara T, et al
    Differences in social functioning among patients with major psychiatric disorders: Interpersonal communication is impaired in patients with schizophrenia and correlates with an increase in schizotypal traits.
    Psychiatry Res. 2016;249:30-34.
    PubMed     Text format     Abstract available


  86. KWONG VW, Chang WC, Chan GH, Jim OT, et al
    Clinical and treatment-related determinants of subjective quality of life in patients with first-episode psychosis.
    Psychiatry Res. 2016;249:39-45.
    PubMed     Text format     Abstract available


  87. KAKELA J, Marttila R, Keskinen E, Veijola J, et al
    Association between family history of psychiatric disorders and long-term outcome in schizophrenia - The Northern Finland Birth Cohort 1966 study.
    Psychiatry Res. 2016;249:16-22.
    PubMed     Text format     Abstract available


  88. BONFILS KA, Lysaker PH, Minor KS, Salyers MP, et al
    Empathy in schizophrenia: A meta-analysis of the Interpersonal Reactivity Index.
    Psychiatry Res. 2016;249:293-303.
    PubMed     Text format     Abstract available


  89. LI Q, Du X, Zhang Y, Yin G, et al
    The prevalence, risk factors and clinical correlates of obesity in Chinese patients with schizophrenia.
    Psychiatry Res. 2016;251:131-136.
    PubMed     Text format     Abstract available


  90. KOCHS A, Kohler S, Merz H, Sterzer P, et al
    Effects of self and familiarity on change detection in patients with schizophrenia.
    Psychiatry Res. 2016;248:140-146.
    PubMed     Text format     Abstract available


  91. POE SL, Brucato G, Bruno N, Arndt LY, et al
    Sleep disturbances in individuals at clinical high risk for psychosis.
    Psychiatry Res. 2016;249:240-243.
    PubMed     Text format     Abstract available


  92. AYDIN E, Cansu Ulgen M, Tabo A, Devrim Balaban O, et al
    Executive function and genetic loading in nonpsychotic relatives of schizophrenia patients.
    Psychiatry Res. 2016;248:105-110.
    PubMed     Text format     Abstract available


  93. EL HAJ M, Altman R, Bortolon C, Capdevielle D, et al
    Destination memory in schizophrenia: "Did I told Elvis Presley about the thief?"
    Psychiatry Res. 2016;248:71-76.
    PubMed     Text format     Abstract available


  94. SON S, Miyata J, Mori Y, Isobe M, et al
    Lateralization of intrinsic frontoparietal network connectivity and symptoms in schizophrenia.
    Psychiatry Res. 2016;260:23-28.
    PubMed     Text format     Abstract available


  95. HSU WY, Muo CH, Ma SP, Kao CH, et al
    Association between schizophrenia and urinary incontinence: A population-based study.
    Psychiatry Res. 2016;248:35-39.
    PubMed     Text format     Abstract available


  96. CUI LB, Chen G, Xu ZL, Liu L, et al
    Cerebral blood flow and its connectivity features of auditory verbal hallucinations in schizophrenia: A perfusion study.
    Psychiatry Res. 2016;260:53-61.
    PubMed     Text format     Abstract available


  97. ANDORKO ND, Mittal V, Thompson E, Denenny D, et al
    The association between sleep dysfunction and psychosis-like experiences among college students.
    Psychiatry Res. 2016;248:6-12.
    PubMed     Text format     Abstract available


  98. CONRAD AM, Lewin TJ, Sly KA, Schall U, et al
    Utility of risk-status for predicting psychosis and related outcomes: evaluation of a 10-year cohort of presenters to a specialised early psychosis community mental health service.
    Psychiatry Res. 2016;247:336-344.
    PubMed     Text format     Abstract available


    November 2016
  99. BUCCI S, Emsley R, Berry K
    Attachment in psychosis: A latent profile analysis of attachment styles and association with symptoms in a large psychosis cohort.
    Psychiatry Res. 2016;247:243-249.
    PubMed     Text format     Abstract available


  100. DOMINGUEZ-MARTINEZ T, Medina-Pradas C, Kwapil TR, Barrantes-Vidal N, et al
    Relatives' expressed emotion, distress and attributions in clinical high-risk and recent onset of psychosis.
    Psychiatry Res. 2016;247:323-329.
    PubMed     Text format     Abstract available


  101. SCHURHOFF F, Leboyer M, Szoke A
    Comorbidity between schizophrenia and keratoconus.
    Psychiatry Res. 2016;247:315-316.
    PubMed     Text format    


  102. ALEGRE M, Molero P, Valencia M, Mayner G, et al
    A typical antipsychotics normalize low-gamma evoked oscillations in patients with schizophrenia.
    Psychiatry Res. 2016;247:214-221.
    PubMed     Text format     Abstract available


  103. BERHANU D, Mattiaccio LM, Antshel KM, Fremont W, et al
    Cortical-amygdala volumetric ratios predict onset of symptoms of psychosis in 22q11.2 deletion syndrome.
    Psychiatry Res. 2016;259:10-15.
    PubMed     Text format     Abstract available


  104. BAUP H, Verdoux H
    Frequency and pattern of Internet use in patients with schizophrenia or bipolar disorders seeking medical information.
    Psychiatry Res. 2016;247:152-154.
    PubMed     Text format     Abstract available


  105. TAKANO Y, Aoki Y, Yahata N, Kawakubo Y, et al
    Neural basis for inferring false beliefs and social emotions in others among individuals with schizophrenia and those at ultra-high risk for psychosis.
    Psychiatry Res. 2016;259:34-41.
    PubMed     Text format     Abstract available


  106. BAS A, Gultekin G, Incir S, Bas TO, et al
    Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics.
    Psychiatry Res. 2016;247:84-89.
    PubMed     Text format     Abstract available


  107. WADA A, Kunii Y, Matsumoto J, Hino M, et al
    Prominent increased calcineurin immunoreactivity in the superior temporal gyrus in schizophrenia: A postmortem study.
    Psychiatry Res. 2016;247:79-83.
    PubMed     Text format     Abstract available


  108. SAVILL M, Orfanos S, Bentall R, Reininghaus U, et al
    The impact of gender on treatment effectiveness of body psychotherapy for negative symptoms of schizophrenia: A secondary analysis of the NESS trial data.
    Psychiatry Res. 2016;247:73-78.
    PubMed     Text format     Abstract available


  109. XU F, Yu T, Niu W, Guo Z, et al
    Association study of NOS1 gene polymorphisms with the risk of schizophrenia in Chinese Han origin.
    Psychiatry Res. 2016 Nov 14. pii: S0165-1781(16)31274.
    PubMed     Text format    


  110. HUSA AP, Moilanen J, Murray GK, Marttila R, et al
    Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort.
    Psychiatry Res. 2016;247:130-138.
    PubMed     Text format     Abstract available


  111. KRAAN TC, Ising HK, Fokkema M, Velthorst E, et al
    The effect of childhood adversity on 4-year outcome in individuals at ultra high risk for psychosis in the Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.
    Psychiatry Res. 2016;247:55-62.
    PubMed     Text format     Abstract available


  112. CORBERA S, Wexler BE, Poltorak A, Thime WR, et al
    Cognitive remediation for adults with schizophrenia: Does age matter?
    Psychiatry Res. 2016;247:21-27.
    PubMed     Text format     Abstract available


  113. ABDEL-BAKI A, Ouellet-Plamondon C, Salvat E, Grar K, et al
    Symptomatic and functional outcomes of substance use disorder persistence 2 years after admission to a first-episode psychosis program.
    Psychiatry Res. 2016;247:113-119.
    PubMed     Text format     Abstract available


  114. ALI A, Carre A, Orri M, Urbach M, et al
    The real-life effectiveness of psychosocial therapies on social autonomy in schizophrenia patients: Results from a nationwide cohort study in France.
    Psychiatry Res. 2016;247:97-104.
    PubMed     Text format     Abstract available


  115. BAI Y, Wang W, Xu J, Zhang F, et al
    Altered resting-state regional homogeneity after 13 weeks of paliperidone injection treatment in schizophrenia patients.
    Psychiatry Res. 2016;258:37-43.
    PubMed     Text format     Abstract available


  116. XIAO W, Ye F, Ma L, Tang X, et al
    Atypical antipsychotic treatment increases glial cell line-derived neurotrophic factor serum levels in drug-free schizophrenic patients along with improvement of psychotic symptoms and therapeutic effects.
    Psychiatry Res. 2016 Nov 3. pii: S0165-1781(16)31176.
    PubMed     Text format     Abstract available


  117. LI H, Zhang Q, Li N, Wang F, et al
    Plasma levels of Th17-related cytokines and complement C3 correlated with aggressive behavior in patients with schizophrenia.
    Psychiatry Res. 2016 Nov 2. pii: S0165-1781(16)30841.
    PubMed     Text format     Abstract available


  118. WALTZMAN D, Knowlton BJ, Cohen JR, Bookheimer SY, et al
    DTI microstructural abnormalities in adolescent siblings of patients with childhood-onset schizophrenia.
    Psychiatry Res. 2016;258:23-29.
    PubMed     Text format    


  119. SUBRAMANIAPILLAI M, Tremblay L, Grassmann V, Remington G, et al
    The effect of an acute bout of exercise on executive function among individuals with schizophrenia.
    Psychiatry Res. 2016 Nov 1. pii: S0165-1781(16)30478.
    PubMed     Text format     Abstract available


  120. AKIYAMA K, Saito S, Saito A, Ozeki Y, et al
    Predictive value of premorbid IQ, negative symptoms, and age for cognitive and social functions in Japanese patients with schizophrenia: A study using the Japanese version of the Brief Assessment of Cognition in Schizophrenia.
    Psychiatry Res. 2016 Nov 1. pii: S0165-1781(16)30546.
    PubMed     Text format     Abstract available


  121. PRIKKEN M, van der Weiden A, Renes RA, Koevoets MG, et al
    Abnormal agency experiences in schizophrenia patients: Examining the role of psychotic symptoms and familial risk.
    Psychiatry Res. 2016;250:270-276.
    PubMed     Text format     Abstract available


    October 2016
  122. SHIN S, Yeom CW, Shin C, Shin JH, et al
    Activity monitoring using a mHealth device and correlations with psychopathology in patients with chronic schizophrenia.
    Psychiatry Res. 2016 Oct 31. pii: S0165-1781(16)30460.
    PubMed     Text format     Abstract available


  123. LEE SC, Tang SF, Lu WS, Huang SL, et al
    Minimal detectable change of the Personal and Social Performance scale in individuals with schizophrenia.
    Psychiatry Res. 2016 Oct 29. pii: S0165-1781(16)30072.
    PubMed     Text format     Abstract available


  124. GARDELLA R, Sacchetti E, Legati A, Magri C, et al
    Compound heterozygosity for a hemizygous rare missense variant (rs141999351) and a large CNV deletion affecting the FSTL5 gene in a patient with schizophrenia.
    Psychiatry Res. 2016 Oct 29. pii: S0165-1781(15)30866.
    PubMed     Text format    


  125. DEMILY C, Louchart-de-la-Chapelle S, Nkam I, Ramoz N, et al
    Does COMT val158met polymorphism influence P50 sensory gating, eye tracking or saccadic inhibition dysfunctions in schizophrenia?
    Psychiatry Res. 2016 Oct 27. pii: S0165-1781(16)30107.
    PubMed     Text format     Abstract available


  126. CAQUEO-URIZAR A, Alessandrini M, Zendjidjian X, Urzua A, et al
    Religion involvement and quality of life in caregivers of patients with schizophrenia in Latin-America.
    Psychiatry Res. 2016 Oct 27. pii: S0165-1781(16)30385.
    PubMed     Text format     Abstract available


  127. PILTON M, Bucci S, McManus J, Hayward M, et al
    Does insecure attachment mediate the relationship between trauma and voice-hearing in psychosis?
    Psychiatry Res. 2016 Oct 26. pii: S0165-1781(16)30038.
    PubMed     Text format     Abstract available


  128. YANG YJ, Xiong JW, Zhao Y, Zhan JQ, et al
    Increased plasma asymmetric dimethylarginine is associated with cognitive deficits in patients with schizophrenia.
    Psychiatry Res. 2016;246:480-484.
    PubMed     Text format     Abstract available


  129. SELLERS R, Gaweda L, Wells A, Morrison AP, et al
    The role of unhelpful metacognitive beliefs in psychosis: Relationships with positive symptoms and negative affect.
    Psychiatry Res. 2016;246:401-406.
    PubMed     Text format     Abstract available


  130. KINOSHITA M, Numata S, Tajima A, Nishi A, et al
    Cumulative effect of the plasma total homocysteine-related genetic variants on schizophrenia risk.
    Psychiatry Res. 2016 Oct 17. pii: S0165-1781(16)30192.
    PubMed     Text format     Abstract available


  131. DOCX L, Emsell L, Van Hecke W, De Bondt T, et al
    White matter microstructure and volitional motor activity in schizophrenia: A diffusion kurtosis imaging study.
    Psychiatry Res. 2016;260:29-36.
    PubMed     Text format     Abstract available


    September 2016
  132. METZLER S, Dvorsky D, Wyss C, Nordt C, et al
    Neurocognition in help-seeking individuals at risk for psychosis: Prediction of outcome after 24 months.
    Psychiatry Res. 2016;246:188-194.
    PubMed     Text format     Abstract available


  133. WANG YX, Zhang P, Xin LM, Chen L, et al
    Chinese version of the Psychotropic-related Sexual Dysfunction Questionnaire (PRSexDQ -SALSEX): Validity and reliability for schizophrenic patients taking antipsychotics.
    Psychiatry Res. 2016;246:303-307.
    PubMed     Text format     Abstract available


  134. TANG XW, Yu M, Duan WW, Zhang XR, et al
    Facial emotion recognition and alexithymia in Chinese male patients with deficit schizophrenia.
    Psychiatry Res. 2016;246:353-359.
    PubMed     Text format     Abstract available


  135. PETRIKIS P, Boumba VA, Tzallas AT, Voulgari PV, et al
    Elevated levels of Insulin-like Growth Factor-1 (IGF-1) in drug-naive patients with psychosis.
    Psychiatry Res. 2016;246:348-352.
    PubMed     Text format     Abstract available


  136. PEREZ-BECERRIL C, Morris AG, Mortimer A, McKenna PJ, et al
    Common variants in the chromosome 2p23 region containing the SLC30A3 (ZnT3) gene are associated with schizophrenia in female but not male individuals in a large collection of European samples.
    Psychiatry Res. 2016;246:335-340.
    PubMed     Text format     Abstract available


  137. PARK HJ, Kim SK, Park JK, Kang WS, et al
    Association between coding single nucleotide polymorphisms in ADAMTS20 and schizophrenia in a Korean population.
    Psychiatry Res. 2016;246:332-334.
    PubMed     Text format    


  138. XI YB, Guo F, Li H, Chang X, et al
    The structural connectivity pathology of first-episode schizophrenia based on the cardinal symptom of auditory verbal hallucinations.
    Psychiatry Res. 2016;257:25-30.
    PubMed     Text format     Abstract available


  139. LAUFFS MM, Shaqiri A, Brand A, Roinishvili M, et al
    Local versus global and retinotopic versus non-retinotopic motion processing in schizophrenia patients.
    Psychiatry Res. 2016;246:461-465.
    PubMed     Text format     Abstract available


  140. COX C, Jolley S, Johns L
    Understanding and treating amotivation in people with psychosis: An experimental study of the role of guided imagery.
    Psychiatry Res. 2016;246:387-391.
    PubMed     Text format     Abstract available


  141. TREMEAU F, Antonius D, Malaspina D, Goff DC, et al
    Loneliness in schizophrenia and its possible correlates. An exploratory study.
    Psychiatry Res. 2016;246:211-217.
    PubMed     Text format     Abstract available


  142. CHEN S, Tian L, Chen N, Xiu M, et al
    Cognitive dysfunction correlates with elevated serum S100B concentration in drug-free acutely relapsed patients with schizophrenia.
    Psychiatry Res. 2016;247:6-11.
    PubMed     Text format     Abstract available


  143. GRILLAULT LAROCHE D, Gaillard A
    Induced Obsessive Compulsive Symptoms (OCS) in schizophrenia patients under Atypical 2 Antipsychotics (AAPs): review and hypotheses.
    Psychiatry Res. 2016;246:119-128.
    PubMed     Text format     Abstract available


  144. PAN S, Tan Y, Yao S, Zhao X, et al
    Serum high-sensitivity C-reactive protein: A delicate sentinel elevated in drug-free acutely agitated patients with schizophrenia.
    Psychiatry Res. 2016;246:89-94.
    PubMed     Text format     Abstract available


  145. FANG SH, Suzuki K, Lim CL, Chung MS, et al
    Associations between sleep quality and inflammatory markers in patients with schizophrenia.
    Psychiatry Res. 2016;246:154-160.
    PubMed     Text format     Abstract available


  146. MAZINANI R, Nejati S, Khodaei M
    Effects of memantine added to risperidone on the symptoms of schizophrenia: A randomized double-blind, placebo-controlled clinical trial.
    Psychiatry Res. 2016;247:291-295.
    PubMed     Text format     Abstract available


  147. HURTADO MM, Trivino M, Arnedo M, Roldan G, et al
    Are executive functions related to emotional intelligence? A correlational study in schizophrenia and borderline personality disorder.
    Psychiatry Res. 2016;246:84-88.
    PubMed     Text format     Abstract available


  148. SIDDI S, Petretto DR, Scanu R, Burrai C, et al
    Deficits in metaphor but not in idiomatic processing are related to verbal hallucinations in patients with psychosis.
    Psychiatry Res. 2016;246:101-112.
    PubMed     Text format     Abstract available


  149. ANDRIC S, Maric NP, Mihaljevic M, Mirjanic T, et al
    Familial covariation of facial emotion recognition and IQ in schizophrenia.
    Psychiatry Res. 2016;246:52-57.
    PubMed     Text format     Abstract available


  150. OLBERT CM, Penn DL, Reise SP, Horan WP, et al
    Assessment of attachment in psychosis: A psychometric cause for concern.
    Psychiatry Res. 2016;246:77-83.
    PubMed     Text format     Abstract available


  151. CHEN X, Duan M, He H, Yang M, et al
    Functional abnormalities of the right posterior insula are related to the altered self-experience in schizophrenia.
    Psychiatry Res. 2016;256:26-32.
    PubMed     Text format     Abstract available


  152. RODRIGUE AL, Austin BP, McDowell JE
    Plasticity of prefrontal cortex connectivity in schizophrenia in response to antisaccade practice.
    Psychiatry Res. 2016 Sep 12. pii: S0925-4927(16)30080.
    PubMed     Text format     Abstract available


  153. TALATI P, Rane S, Donahue MJ, Heckers S, et al
    Hippocampal arterial cerebral blood volume in early psychosis.
    Psychiatry Res. 2016;256:21-25.
    PubMed     Text format     Abstract available


  154. REED AC, Harris JG, Olincy A
    Schizophrenia, smoking status, and performance on the matrics Cognitive Consensus Battery.
    Psychiatry Res. 2016;246:1-8.
    PubMed     Text format     Abstract available


    August 2016
  155. VASCONCELOS E SA D, Wearden A, Hartley S, Emsley R, et al
    Expressed Emotion and behaviourally controlling interactions in the daily life of dyads experiencing psychosis.
    Psychiatry Res. 2016;245:406-413.
    PubMed     Text format     Abstract available


  156. YANG B, Niu W, Chen S, Xu F, et al
    Association study of dopamine receptor genes polymorphisms with the risk of schizophrenia in the Han Chinese population.
    Psychiatry Res. 2016;245:361-364.
    PubMed     Text format     Abstract available


  157. CHASE KA, Feiner B, Rosen C, Gavin DP, et al
    Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia.
    Psychiatry Res. 2016;245:346-353.
    PubMed     Text format     Abstract available


  158. ESSHILI A, Thabet S, Jemli A, Trifa F, et al
    Toxoplasma gondii infection in schizophrenia and associated clinical features.
    Psychiatry Res. 2016;245:327-332.
    PubMed     Text format     Abstract available


  159. ZHOU Y, Ning Y, Rosenheck R, Sun B, et al
    Effect of living with patients on caregiver burden of individual with schizophrenia in China.
    Psychiatry Res. 2016;245:230-237.
    PubMed     Text format     Abstract available


  160. KUMAR V, Rao NP, Narasimha V, Sathyanarayanan G, et al
    Antipsychotic dose in maintenance treatment of schizophrenia: A retrospective study.
    Psychiatry Res. 2016;245:311-316.
    PubMed     Text format     Abstract available


  161. ZHOU J, Xiang YT, Li Q, Zhu X, et al
    Gender differences in attitudes towards antipsychotic medications in patients with schizophrenia.
    Psychiatry Res. 2016;245:276-281.
    PubMed     Text format     Abstract available


  162. ALACAM H, Akgun S, Akca H, Ozturk O, et al
    miR-181b-5p, miR-195-5p and miR-301a-3p are related with treatment resistance in schizophrenia.
    Psychiatry Res. 2016;245:200-206.
    PubMed     Text format     Abstract available


  163. LUTHER L, Firmin RL, Minor KS, Vohs JL, et al
    Metacognition deficits as a risk factor for prospective motivation deficits in schizophrenia spectrum disorders.
    Psychiatry Res. 2016;245:172-178.
    PubMed     Text format     Abstract available


  164. BUTJOSA A, Gomez-Benito J, Huerta-Ramos E, Del Cacho N, et al
    Incidence of stressful life events and influence of sociodemographic and clinical variables on the onset of first-episode psychosis.
    Psychiatry Res. 2016;245:108-115.
    PubMed     Text format     Abstract available


  165. SUMIYOSHI C, Fujino H, Sumiyoshi T, Yasuda Y, et al
    Usefulness of the Wechsler Intelligence Scale short form for assessing functional outcomes in patients with schizophrenia.
    Psychiatry Res. 2016;245:371-378.
    PubMed     Text format     Abstract available


  166. MAUSBACH BT, Tiznado D, Cardenas V, Jeste DV, et al
    Validation of the UCSD Performance-based Skills Assessment (UPSA) in Hispanics with and without schizophrenia.
    Psychiatry Res. 2016;244:388-393.
    PubMed     Text format     Abstract available


  167. BURANEE K, Teeradej S, Chusak L, Michael M, et al
    Epilepsy-related psychoses and psychotic symptoms are significantly reduced by resective epilepsy surgery and are not associated with surgery outcome or epilepsy characteristics: A cohort study.
    Psychiatry Res. 2016;245:333-339.
    PubMed     Text format     Abstract available


  168. VANES LD, White TP, Wigton RL, Joyce D, et al
    Reduced susceptibility to the sound-induced flash fusion illusion in schizophrenia.
    Psychiatry Res. 2016;245:58-65.
    PubMed     Text format     Abstract available


  169. AYDIN O, Balikci K, Tas C, Aydin PU, et al
    The developmental origins of metacognitive deficits in schizophrenia.
    Psychiatry Res. 2016;245:15-21.
    PubMed     Text format     Abstract available


  170. BONFILS KA, Luther L, Firmin RL, Lysaker PH, et al
    Language and hope in schizophrenia-spectrum disorders.
    Psychiatry Res. 2016;245:8-14.
    PubMed     Text format     Abstract available


  171. SU CY, Wang PW, Lin YJ, Tang TC, et al
    The effects of aerobic exercise on cognition in schizophrenia: A 3-month follow-up study.
    Psychiatry Res. 2016;244:394-402.
    PubMed     Text format     Abstract available


  172. PANG B, Wang J, Zhang W, Gao Y, et al
    Increased histone deacetylase activity in peripheral blood mononuclear cells of patients with schizophrenia.
    Psychiatry Res. 2016;245:105-107.
    PubMed     Text format     Abstract available


  173. KARANIKAS E, Griveas I, Ntouros E, Floros G, et al
    Evidence for increased immune mobilization in First Episode Psychosis compared with the prodromal stage in males.
    Psychiatry Res. 2016;244:333-338.
    PubMed     Text format     Abstract available


    July 2016
  174. MINGRONE C, Montemagni C, Sandei L, Bava I, et al
    Coping strategies in schizoaffective disorder and schizophrenia: Differences and similarities.
    Psychiatry Res. 2016;244:317-323.
    PubMed     Text format     Abstract available


  175. VIZZOTTO AD, Celestino DL, Buchain PC, Oliveira AM, et al
    A pilot randomized controlled trial of the Occupational Goal Intervention method for the improvement of executive functioning in patients with treatment-resistant schizophrenia.
    Psychiatry Res. 2016;245:148-156.
    PubMed     Text format     Abstract available


  176. SUN ZL, Liu J, Guo W, Jiang T, et al
    Serum brain-derived neurotrophic factor levels associate with cognitive improvement in patients with schizophrenia treated with electroacupuncture.
    Psychiatry Res. 2016;244:370-375.
    PubMed     Text format     Abstract available


  177. TAKEUCHI H, Fervaha G, Remington G
    Reliability of a patient-reported outcome measure in schizophrenia: Results from back-to-back self-ratings.
    Psychiatry Res. 2016;244:415-419.
    PubMed     Text format     Abstract available


  178. EDWARDS CJ, Cella M, Tarrier N, Wykes T, et al
    The optimisation of experience sampling protocols in people with schizophrenia.
    Psychiatry Res. 2016;244:289-293.
    PubMed     Text format     Abstract available


  179. HU KF, Chou YH, Wen YH, Hsieh KP, et al
    Antipsychotic medications and dental caries in newly diagnosed schizophrenia: A nationwide cohort study.
    Psychiatry Res. 2016;245:45-50.
    PubMed     Text format     Abstract available


  180. CHEN XJ, Liu LL, Cui JF, Gan MY, et al
    The effect and mechanisms of implementation intention in improving prospective memory performance in schizophrenia patients.
    Psychiatry Res. 2016;244:86-93.
    PubMed     Text format     Abstract available


  181. CAO B, Wang DF, Xu MY, Liu YQ, et al
    Lower folate levels in schizophrenia: A meta-analysis.
    Psychiatry Res. 2016;245:1-7.
    PubMed     Text format     Abstract available


  182. RISPAUD SG, Rose J, Kurtz MM
    The relationship between change in cognition and change in functional ability in schizophrenia during cognitive and psychosocial rehabilitation.
    Psychiatry Res. 2016;244:145-150.
    PubMed     Text format     Abstract available


  183. ROOPRAM SM, Burger AM, van Dijk DA, Enterman J, et al
    A pilot study of bright light therapy in schizophrenia.
    Psychiatry Res. 2016;245:317-320.
    PubMed     Text format     Abstract available


  184. GARG S, Sinha VK, Tikka SK, Mishra P, et al
    The efficacy of cerebellar vermal deep high frequency (theta range) repetitive transcranial magnetic stimulation (rTMS) in schizophrenia: A randomized rater blind-sham controlled study.
    Psychiatry Res. 2016;243:413-420.
    PubMed     Text format     Abstract available


  185. DELICE M, Gurbuz O, Oflezer C, Kurt E, et al
    Palate size and shape in schizophrenia.
    Psychiatry Res. 2016;244:273-278.
    PubMed     Text format     Abstract available


  186. PILLNY M, Lincoln TM
    Predictors of improved functioning in patients with psychosis: The role of amotivation and defeatist performance beliefs.
    Psychiatry Res. 2016;244:117-122.
    PubMed     Text format     Abstract available


  187. TEIGSET CM, Mohn C, Rund BR
    Gestational length affects neurocognition in early-onset schizophrenia.
    Psychiatry Res. 2016;244:78-85.
    PubMed     Text format     Abstract available


  188. GREEN AE, Croft RJ, Maller JJ, Fitzgerald PB, et al
    White matter correlates of episodic memory encoding and retrieval in schizophrenia.
    Psychiatry Res. 2016;254:188-198.
    PubMed     Text format     Abstract available


  189. SANKARANARAYANAN A, Clark V, Baker A, Palazzi K, et al
    Reducing smoking reduces suicidality among individuals with psychosis: Complementary outcomes from a Healthy Lifestyles intervention study.
    Psychiatry Res. 2016;243:407-412.
    PubMed     Text format     Abstract available


  190. KOIVUKANGAS J, Bjornholm L, Tervonen O, Miettunen J, et al
    Body mass index and brain white matter structure in young adults at risk for psychosis - The Oulu Brain and Mind Study.
    Psychiatry Res. 2016;254:169-176.
    PubMed     Text format     Abstract available


  191. LIU L, Luo Y, Zhang G, Jin C, et al
    The mRNA expression of DRD2, PI3KCB, and AKT1 in the blood of acute schizophrenia patients.
    Psychiatry Res. 2016;243:397-402.
    PubMed     Text format     Abstract available


  192. YEE JY, See YM, Abdul Rashid NA, Neelamekam S, et al
    Association between serum levels of bioavailable vitamin D and negative symptoms in first-episode psychosis.
    Psychiatry Res. 2016;243:390-394.
    PubMed     Text format     Abstract available


  193. OHMURO N, Katsura M, Obara C, Kikuchi T, et al
    Deficits of cognitive theory of mind and its relationship with functioning in individuals with an at-risk mental state and first-episode psychosis.
    Psychiatry Res. 2016;243:318-325.
    PubMed     Text format     Abstract available


  194. LIU YW, Tzeng NS, Yeh CB, Kuo TB, et al
    Reduced cardiac autonomic response to deep breathing: A heritable vulnerability trait in patients with schizophrenia and their healthy first-degree relatives.
    Psychiatry Res. 2016;243:335-341.
    PubMed     Text format     Abstract available


  195. CHEN SD, Sun XY, Niu W, Kong LM, et al
    A preliminary analysis of microRNA-21 expression alteration after antipsychotic treatment in patients with schizophrenia.
    Psychiatry Res. 2016;244:324-332.
    PubMed     Text format     Abstract available


    June 2016
  196. IDRIZI R, Malcolm P, Weickert CS, Zavitsanou K, et al
    Striatal but not frontal cortical up-regulation of the epidermal growth factor receptor in rats exposed to immune activation in utero and cannabinoid treatment in adolescence.
    Psychiatry Res. 2016;240:260-4.
    PubMed     Text format     Abstract available


  197. XU Z, Mayer B, Muller M, Heekeren K, et al
    Stigma and suicidal ideation among young people at risk of psychosis after one year.
    Psychiatry Res. 2016;243:219-224.
    PubMed     Text format     Abstract available


  198. FONSECA-PEDRERO E, Gooding DC, Ortuno-Sierra J, Pflum M, et al
    Classifying risk status of non-clinical adolescents using psychometric indicators for psychosis spectrum disorders.
    Psychiatry Res. 2016;243:246-254.
    PubMed     Text format     Abstract available


  199. TOH WL, Castle DJ, Thomas N, Badcock JC, et al
    Auditory verbal hallucinations (AVHs) and related psychotic phenomena in mood disorders: analysis of the 2010 Survey of High Impact Psychosis (SHIP) data.
    Psychiatry Res. 2016;243:238-245.
    PubMed     Text format     Abstract available


  200. LIEBENBERG R, van Heerden B, Ehlers R, Du Plessis AM, et al
    Advancing paternal age at birth is associated with poorer social functioning earlier and later in life of schizophrenia patients in a founder population.
    Psychiatry Res. 2016;243:185-190.
    PubMed     Text format     Abstract available


  201. GROVE TB, Tso IF, Chun J, Mueller SA, et al
    Negative affect predicts social functioning across schizophrenia and bipolar disorder: Findings from an integrated data analysis.
    Psychiatry Res. 2016;243:198-206.
    PubMed     Text format     Abstract available


  202. KAGEYAMA M, Solomon P, Kita S, Nagata S, et al
    Factors related to physical violence experienced by parents of persons with schizophrenia in Japan.
    Psychiatry Res. 2016;243:439-445.
    PubMed     Text format     Abstract available


  203. LEE JS, Kim ES, Kim EJ, Kim J, et al
    The relationship between self-referential processing-related brain activity and anhedonia in patients with schizophrenia.
    Psychiatry Res. 2016;254:112-118.
    PubMed     Text format     Abstract available


  204. MAO WC, Chen LF, Chi CH, Lin CH, et al
    Traditional Chinese version of the Mayer Salovey Caruso Emotional Intelligence Test (MSCEIT-TC): Its validation and application to schizophrenic individuals.
    Psychiatry Res. 2016;243:61-70.
    PubMed     Text format     Abstract available


  205. DEVRIM-UCOK M, Keskin-Ergen Y, Ucok A
    Lack of progressive reduction in P3 amplitude after the first-episode of schizophrenia: A 6-year follow-up study.
    Psychiatry Res. 2016;243:303-311.
    PubMed     Text format     Abstract available


  206. SCIOR K, Furnham A
    Causal beliefs about intellectual disability and schizophrenia and their relationship with awareness of the condition and social distance.
    Psychiatry Res. 2016;243:100-108.
    PubMed     Text format     Abstract available


  207. COBO J, Nieto L, Ochoa S, Pousa E, et al
    Insight and gender in schizophrenia and other psychoses.
    Psychiatry Res. 2016;243:268-277.
    PubMed     Text format     Abstract available


  208. HUANG TL, Lin CC, Chen RF, Lee CT, et al
    Higher blood MLL1 mRNA and BDNF promoter IV on histone H3K4me3 levels in patients with schizophrenia.
    Psychiatry Res. 2016;243:207-209.
    PubMed     Text format     Abstract available


  209. PAOLINI E, Moretti P, Compton MT
    Delusions in first-episode psychosis: Principal component analysis of twelve types of delusions and demographic and clinical correlates of resulting domains.
    Psychiatry Res. 2016;243:5-13.
    PubMed     Text format     Abstract available


  210. MACDOUGALL AG, Vandermeer MR, Norman RM
    Determinants of self-esteem in early psychosis: The role of perceived social dominance.
    Psychiatry Res. 2016 Jun 11. pii: S0165-1781(15)30270.
    PubMed     Text format     Abstract available


  211. DE ROSSI P, Dacquino C, Piras F, Caltagirone C, et al
    Left nucleus accumbens atrophy in deficit schizophrenia: A preliminary study.
    Psychiatry Res. 2016;254:48-55.
    PubMed     Text format     Abstract available


  212. ALLOZA C, Cox SR, Duff B, Semple SI, et al
    Information processing speed mediates the relationship between white matter and general intelligence in schizophrenia.
    Psychiatry Res. 2016;254:26-33.
    PubMed     Text format     Abstract available


  213. BUCHY L, Mathalon DH, Cannon TD, Cadenhead KS, et al
    Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis.
    Psychiatry Res. 2016;254:3-9.
    PubMed     Text format     Abstract available


  214. CHANG WC, Lau CF, Chan SS, Hui CL, et al
    Premorbid, clinical and cognitive correlates of primary negative symptoms in first-episode psychosis.
    Psychiatry Res. 2016;242:144-149.
    PubMed     Text format     Abstract available


  215. FERVAHA G, Agid O, Takeuchi H, Foussias G, et al
    Life satisfaction and happiness among young adults with schizophrenia.
    Psychiatry Res. 2016;242:174-179.
    PubMed     Text format     Abstract available


    May 2016
  216. BROWNE J, Penn DL, Raykov T, Pinkham AE, et al
    Social cognition in schizophrenia: Factor structure of emotion processing and theory of mind.
    Psychiatry Res. 2016;242:150-156.
    PubMed     Text format     Abstract available


  217. UNDERWOOD R, Kumari V, Peters E
    Cognitive and neural models of threat appraisal in psychosis: A theoretical integration.
    Psychiatry Res. 2016;239:131-8.
    PubMed     Text format     Abstract available


  218. KASCKOW J, Zickmund S, Gurklis J, Luther J, et al
    Using telehealth to augment an intensive case monitoring program in veterans with schizophrenia and suicidal ideation: A pilot trial.
    Psychiatry Res. 2016;239:111-6.
    PubMed     Text format     Abstract available


  219. PEITL V, Vidrih B, Karlovic Z, Getaldic B, et al
    Platelet serotonin concentration and depressive symptoms in patients with schizophrenia.
    Psychiatry Res. 2016;239:105-10.
    PubMed     Text format     Abstract available


  220. CAVELTI M, Homan P, Vauth R
    The impact of thought disorder on therapeutic alliance and personal recovery in schizophrenia and schizoaffective disorder: An exploratory study.
    Psychiatry Res. 2016;239:92-8.
    PubMed     Text format     Abstract available


  221. RAKITZI S, Georgila P, Efthimiou K, Mueller DR, et al
    Efficacy and feasibility of the Integrated Psychological Therapy for outpatients with schizophrenia in Greece: Final results of a RCT.
    Psychiatry Res. 2016;242:137-143.
    PubMed     Text format     Abstract available


  222. VERGARA-MORAGUES E, Mestre-Pinto JI, Gomez PA, Rodriguez-Fonseca F, et al
    Can symptoms help in differential diagnosis between substance-induced vs independent psychosis in adults with a lifetime diagnosis of cocaine use disorder?
    Psychiatry Res. 2016;242:94-100.
    PubMed     Text format     Abstract available


  223. MENDES-FILHO VA, de Jesus DR, Belmonte-de-Abreu P, Cachoeira CT, et al
    Effects of repetitive transcranial magnetic stimulation over supplementary motor area in patients with schizophrenia with obsessive-compulsive-symptoms: A pilot study.
    Psychiatry Res. 2016;242:34-38.
    PubMed     Text format     Abstract available


  224. BERRADA-BABY Z, Oker A, Courgeon M, Urbach M, et al
    Patients with schizophrenia are less prone to interpret virtual others' empathetic questioning as helpful.
    Psychiatry Res. 2016;242:67-74.
    PubMed     Text format     Abstract available


  225. STRZELECKI D, Kaluzynska O, Wysokinski A
    BDNF serum levels in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study).
    Psychiatry Res. 2016;242:54-60.
    PubMed     Text format     Abstract available


  226. OLSSON AK, Hjarthag F, Helldin L
    Predicting real-world functional milestones in schizophrenia.
    Psychiatry Res. 2016;242:1-6.
    PubMed     Text format     Abstract available


  227. SHAIKH M, Ellett L, Dutt A, Day F, et al
    Perceived ethnic discrimination and persecutory paranoia in individuals at ultra-high risk for psychosis.
    Psychiatry Res. 2016;241:309-314.
    PubMed     Text format     Abstract available


  228. BUOLI M, Bertino V, Caldiroli A, Dobrea C, et al
    Are obstetrical complications really involved in the etiology and course of schizophrenia and mood disorders?
    Psychiatry Res. 2016;241:297-301.
    PubMed     Text format     Abstract available


  229. WU L, Chen F, Wei J, Shen Y, et al
    Study of the tetraspanin 18 association with schizophrenia in a Han Chinese population.
    Psychiatry Res. 2016;241:263-266.
    PubMed     Text format     Abstract available


  230. BUCHTEMANN D, Kastner D, Warnke I, Radisch J, et al
    Hospital utilization outcome of an assertive outreach model for schizophrenic patients - results of a quasi-experimental study.
    Psychiatry Res. 2016;241:249-255.
    PubMed     Text format     Abstract available


  231. FERNANDEZ G, Guinjoan S, Sapognikoff M, Orozco D, et al
    Contextual predictability enhances reading performance in patients with schizophrenia.
    Psychiatry Res. 2016;241:333-339.
    PubMed     Text format     Abstract available


  232. KIMURA H, Kanahara N, Takase M, Yoshida T, et al
    A randomized, sham-controlled study of high frequency rTMS for auditory hallucination in schizophrenia.
    Psychiatry Res. 2016;241:190-194.
    PubMed     Text format     Abstract available


  233. SINGH A, Mattoo SK, Grover S
    Stigma and its correlates among caregivers of schizophrenia: A study from North India.
    Psychiatry Res. 2016;241:302-308.
    PubMed     Text format     Abstract available


  234. SEVOS J, Grosselin A, Fedotova T, Massoubre C, et al
    Behavioral predispositions to approach or avoid emotional words in schizophrenia.
    Psychiatry Res. 2016;241:195-200.
    PubMed     Text format     Abstract available


  235. ONG HL, Subramaniam M, Abdin E, Wang P, et al
    Performance of Mini-Mental State Examination (MMSE) in long-stay patients with schizophrenia or schizoaffective disorders in a psychiatric institute.
    Psychiatry Res. 2016;241:256-262.
    PubMed     Text format     Abstract available


  236. GRAU N, Rubio-Abadal E, Usall J, Barajas A, et al
    Influence of cognition, premorbid adjustment and psychotic symptoms on psycho-social functioning in first-episode psychosis.
    Psychiatry Res. 2016;242:157-162.
    PubMed     Text format     Abstract available


    April 2016
  237. HOLLANDER S, Hochman E, Shoval G, Taler M, et al
    The association between serum creatine kinase, mood and psychosis in inpatients with schizophrenia, bipolar and schizoaffective disorders.
    Psychiatry Res. 2016;238:333-7.
    PubMed     Text format     Abstract available


  238. LEDDY-STACY MA, Rosenheck R
    Obtaining employment as an anchor for estimating the minimum clinically important difference on the Positive and Negative Syndrome Scale (PANSS) in schizophrenia.
    Psychiatry Res. 2016;238:304-9.
    PubMed     Text format     Abstract available


  239. MADEIRA L, Bonoldi I, Rocchetti M, Brandizzi M, et al
    Prevalence and implications of Truman symptoms in subjects at ultra high risk for psychosis.
    Psychiatry Res. 2016;238:270-6.
    PubMed     Text format     Abstract available


  240. SMITH EA, Bolinskey PK, Guidi JP, Myers KR, et al
    Further examination of the factor structure of the Chapman Psychosis Proneness Scales (CPPS).
    Psychiatry Res. 2016;238:257-63.
    PubMed     Text format     Abstract available


  241. EISENACHER S, Rausch F, Mier D, Fenske S, et al
    Bias against disconfirmatory evidence in the 'at-risk mental state' and during psychosis.
    Psychiatry Res. 2016;238:242-50.
    PubMed     Text format     Abstract available


  242. KALISZ A, Cechnicki A
    The stability of negative syndrome, persistent negative syndrome and deficit syndrome in a twenty-year follow-up study of schizophrenia patients.
    Psychiatry Res. 2016;238:236-41.
    PubMed     Text format     Abstract available


  243. SCHOLTE-STALENHOEF AN, la Bastide-van Gemert S, van de Willige G, Dost-Otter R, et al
    Personality and coping in first episode psychosis linked to mental health care use.
    Psychiatry Res. 2016;238:218-24.
    PubMed     Text format     Abstract available


  244. NONAKA-HASHIDA S, Sekine M, Ozeki Y, Fujii K, et al
    Plasma concentrations of three methylated arginines, endogenous nitric oxide synthase inhibitors, in schizophrenic patients undergoing antipsychotic drug treatment.
    Psychiatry Res. 2016;238:203-10.
    PubMed     Text format     Abstract available


  245. WU JQ, Chen da C, Tan YL, Xiu MH, et al
    Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: MATRICS consensus cognitive battery in a Chinese Han population.
    Psychiatry Res. 2016;238:196-202.
    PubMed     Text format     Abstract available


  246. MARCO C, Antonio D, Antonina S, Alessandro S, et al
    Corrigendum to "Genes involved in pruning and inflammation are enriched in a large mega-sample of patients affected by schizophrenia and bipolar disorder and controls" [Psychiatry Res. 228 (2015) 945-949].
    Psychiatry Res. 2016;238:165.
    PubMed     Text format    


  247. TREMEAU F, Antonius D, Todorov A, Rebani Y, et al
    What can the study of first impressions tell us about attitudinal ambivalence and paranoia in schizophrenia?
    Psychiatry Res. 2016;238:86-92.
    PubMed     Text format     Abstract available


  248. MISIAK B, Laczmanski L, Sloka NK, Szmida E, et al
    Metabolic dysregulation in first-episode schizophrenia patients with respect to genetic variation in one-carbon metabolism.
    Psychiatry Res. 2016;238:60-7.
    PubMed     Text format     Abstract available


  249. PARK IJ, Jung DC, Hwang SS, Jung HY, et al
    The longitudinal trends in the relationship between drug-induced extrapyramidal symptoms and personal and social performance in a population of the patients with schizophrenia: A latent growth model.
    Psychiatry Res. 2016;238:33-9.
    PubMed     Text format     Abstract available


  250. PALMIER-CLAUS J, Berry K, Darrell-Berry H, Emsley R, et al
    Childhood adversity and social functioning in psychosis: Exploring clinical and cognitive mediators.
    Psychiatry Res. 2016;238:25-32.
    PubMed     Text format     Abstract available


  251. TRAUELSEN AM, Gumley A, Jansen JE, Pedersen MB, et al
    Metacognition in first-episode psychosis and its association with positive and negative symptom profiles.
    Psychiatry Res. 2016;238:14-23.
    PubMed     Text format     Abstract available


  252. NORDHOLM D, Poulsen HE, Hjorthoj C, Randers L, et al
    Systemic oxidative DNA and RNA damage are not increased during early phases of psychosis: A case control study.
    Psychiatry Res. 2016;241:201-206.
    PubMed     Text format     Abstract available


  253. DAVIDSON CA, Hoffman L, Spaulding WD
    Schizotypal personality questionnaire--brief revised (updated): An update of norms, factor structure, and item content in a large non-clinical young adult sample.
    Psychiatry Res. 2016;238:345-55.
    PubMed     Text format     Abstract available


  254. RASMUSSEN SA, Rosebush PI, Anglin RE, Mazurek MF, et al
    The predictive value of early treatment response in antipsychotic-naive patients with first-episode psychosis: Haloperidol versus olanzapine.
    Psychiatry Res. 2016;241:72-77.
    PubMed     Text format     Abstract available


  255. JIN C, Zhou Z, Li W, Zhang F, et al
    Analysis of the association of VIPR2 polymorphisms with susceptibility to schizophrenia.
    Psychiatry Res. 2016;241:104-107.
    PubMed     Text format     Abstract available


  256. GONZALEZ-LIENCRES C, Brown EC, Tas C, Breidenstein A, et al
    Alterations in event-related potential responses to empathy for pain in schizophrenia.
    Psychiatry Res. 2016;241:14-21.
    PubMed     Text format     Abstract available


  257. KORKMAZ S, Korkmaz H, Ozer O, Atmaca M, et al
    Assessment of left ventricle systolic and diastolic functions in schizophrenia patients.
    Psychiatry Res. 2016;240:348-351.
    PubMed     Text format     Abstract available


  258. BULZACKA E, Delourme G, Hutin V, Burban N, et al
    Clinical utility of the Multiple Errands Test in schizophrenia: A preliminary assessment.
    Psychiatry Res. 2016;240:390-397.
    PubMed     Text format     Abstract available


  259. WILLI TS, Honer WG, Thornton AE, Gicas K, et al
    Factors affecting severity of positive and negative symptoms of psychosis in a polysubstance using population with psychostimulant dependence.
    Psychiatry Res. 2016;240:336-342.
    PubMed     Text format     Abstract available


  260. LI Z, Yin M, Lyu XL, Zhang LL, et al
    Delayed effect of repetitive transcranial magnetic stimulation (rTMS) on negative symptoms of schizophrenia: Findings from a randomized controlled trial.
    Psychiatry Res. 2016;240:333-335.
    PubMed     Text format     Abstract available


  261. TELO S, Gurok MG
    Asymmetric dimethylarginine (ADMA), 4-OH-nonenal and Vitamin E levels in chronic schizophrenic patients.
    Psychiatry Res. 2016;240:295-299.
    PubMed     Text format    


  262. JHA S, Garg A
    Add on testosterone therapy in negative symptoms of schizophrenia with gonadal trauma: Hitting the bull's eye.
    Psychiatry Res. 2016;240:265-266.
    PubMed     Text format     Abstract available


  263. FARNIA V, Shakeri J, Tatari F, Juibari TA, et al
    Demographic and mental history-related data predicted occurrence of psychosis in metamphetamine users.
    Psychiatry Res. 2016;240:431-434.
    PubMed     Text format     Abstract available


  264. BAANDRUP L, Glenthoj BY, Jennum PJ
    Objective and subjective sleep quality: Melatonin versus placebo add-on treatment in patients with schizophrenia or bipolar disorder withdrawing from long-term benzodiazepine use.
    Psychiatry Res. 2016;240:163-169.
    PubMed     Text format     Abstract available


  265. MAO Q, Tan YL, Luo XG, Tian L, et al
    Association of catechol-O-methyltransferase Val108/158 Met genetic polymorphism with schizophrenia, P50 sensory gating, and negative symptoms in a Chinese population.
    Psychiatry Res. 2016;242:271-276.
    PubMed     Text format     Abstract available


  266. MORRISON AP, Burke E, Murphy E, Pyle M, et al
    Cognitive therapy for internalised stigma in people experiencing psychosis: A pilot randomised controlled trial.
    Psychiatry Res. 2016;240:96-102.
    PubMed     Text format     Abstract available


  267. JOYAL M, Bonneau A, Fecteau S
    Speech and language therapies to improve pragmatics and discourse skills in patients with schizophrenia.
    Psychiatry Res. 2016;240:88-95.
    PubMed     Text format     Abstract available


  268. KOUTRA K, Simos P, Triliva S, Lionis C, et al
    Linking family cohesion and flexibility with expressed emotion, family burden and psychological distress in caregivers of patients with psychosis: A path analytic model.
    Psychiatry Res. 2016;240:66-75.
    PubMed     Text format     Abstract available


  269. FEINGOLD D, Hasson-Ohayon I, Laukka P, Vishne T, et al
    Emotion recognition deficits among persons with schizophrenia: Beyond stimulus complexity level and presentation modality.
    Psychiatry Res. 2016;240:60-65.
    PubMed     Text format     Abstract available


  270. OHI K, Shimada T, Nitta Y, Kihara H, et al
    The Five-Factor Model personality traits in schizophrenia: A meta-analysis.
    Psychiatry Res. 2016;240:34-41.
    PubMed     Text format     Abstract available


  271. CHARAN A, Shewade DG, Rajkumar RP, Chandrasekaran A, et al
    Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia.
    Psychiatry Res. 2016;240:209-213.
    PubMed     Text format     Abstract available


  272. VOGEL B, Bruck C, Jacob H, Eberle M, et al
    Integration of verbal and nonverbal emotional signals in patients with schizophrenia: Decreased nonverbal dominance.
    Psychiatry Res. 2016;241:98-103.
    PubMed     Text format     Abstract available


    March 2016
  273. JIN C, Zhang X, Liu X, Li W, et al
    Association study of KIBRA rs17070145 polymorphism with the risk of schizophrenia in the Han Chinese population.
    Psychiatry Res. 2016;239:331-332.
    PubMed     Text format    


  274. HUDDY V, Drake G, Wykes T
    Mental simulation and experience as determinants of performance expectancies in people with schizophrenia spectrum disorder.
    Psychiatry Res. 2016;237:97-102.
    PubMed     Text format     Abstract available


  275. GOMES E, Bastos T, Probst M, Ribeiro JC, et al
    Reliability and validity of 6MWT for outpatients with schizophrenia: A preliminary study.
    Psychiatry Res. 2016;237:37-42.
    PubMed     Text format     Abstract available


  276. BATTY RA, Francis A, Thomas N, Hopwood M, et al
    A brief neurocognitive assessment of patients with psychosis following traumatic brain injury (PFTBI): Use of the Repeatable battery for the Assessment of Neuropsychological Status (RBANS).
    Psychiatry Res. 2016;237:27-36.
    PubMed     Text format     Abstract available


  277. GRANO N, Karjalainen M, Ranta K, Lindgren M, et al
    Community-oriented family-based intervention superior to standard treatment in improving depression, hopelessness and functioning among adolescents with any psychosis-risk symptoms.
    Psychiatry Res. 2016;237:9-16.
    PubMed     Text format     Abstract available


  278. FAGET-AGIUS C, Boyer L, Richieri R, Auquier P, et al
    Functional brain substrate of quality of life in patients with schizophrenia: A brain SPECT multidimensional analysis.
    Psychiatry Res. 2016;249:67-75.
    PubMed     Text format     Abstract available


  279. ZHENG J, Zhang Y, Guo X, Duan X, et al
    Disrupted amplitude of low-frequency fluctuations in antipsychotic-naive adolescents with early-onset schizophrenia.
    Psychiatry Res. 2016;249:20-6.
    PubMed     Text format     Abstract available


  280. KIM EY, Kim SH, Lee HJ, Kim B, et al
    Sex-specific association between the albumin D-element binding protein gene and metabolic syndrome in patients with bipolar disorder and schizophrenia.
    Psychiatry Res. 2016;240:47-52.
    PubMed     Text format    


  281. QIAO Y, Yang F, Li C, Guo Q, et al
    Add-on effects of a low-dose aripiprazole in resolving hyperprolactinemia induced by risperidone or paliperidone.
    Psychiatry Res. 2016;237:83-9.
    PubMed     Text format     Abstract available


  282. MARQUEZ-ARRICO JE, Lopez-Vera S, Prat G, Adan A, et al
    Temperament and character dimensions in male patients with substance use disorders: Differences relating to psychiatric comorbidity.
    Psychiatry Res. 2016;237:1-8.
    PubMed     Text format     Abstract available


  283. LANGSRUD K, Vaaler AE, Kallestad H, Morken G, et al
    Sleep patterns as a predictor for length of stay in a psychiatric intensive care unit.
    Psychiatry Res. 2016;237:252-6.
    PubMed     Text format     Abstract available


  284. CARRA G, Johnson S, Crocamo C, Angermeyer MC, et al
    Psychosocial functioning, quality of life and clinical correlates of comorbid alcohol and drug dependence syndromes in people with schizophrenia across Europe.
    Psychiatry Res. 2016;239:301-307.
    PubMed     Text format     Abstract available


  285. BERNARDINI F, Lunden A, Covington M, Broussard B, et al
    Associations of acoustically measured tongue/jaw movements and portion of time speaking with negative symptom severity in patients with schizophrenia in Italy and the United States.
    Psychiatry Res. 2016;239:253-258.
    PubMed     Text format     Abstract available


  286. SHI J, Wang L, Yao Y, Chen F, et al
    Protective factors in Chinese university students at clinical high risk for psychosis.
    Psychiatry Res. 2016;239:239-244.
    PubMed     Text format     Abstract available


  287. LANG FU, Muller-Stierlin AS, Walther S, Stegmayer K, et al
    Dimensional approaches to schizophrenia: A comparison of the Bern Psychopathology scale and the five-factor model of the Positive and Negative Syndrome Scale.
    Psychiatry Res. 2016;239:284-290.
    PubMed     Text format     Abstract available


  288. TAKAHASHI T, Nakamura M, Nishikawa Y, Takayanagi Y, et al
    Decreased number of orbital sulci in schizophrenia spectrum disorders.
    Psychiatry Res. 2016;250:29-32.
    PubMed     Text format     Abstract available


  289. ONIKI K, Kamihashi R, Tomita T, Ishioka M, et al
    Glutathione S-transferase K1 genotype and overweight status in schizophrenia patients: A pilot study.
    Psychiatry Res. 2016;239:190-195.
    PubMed     Text format     Abstract available


  290. ALAMEDA L, Golay P, Baumann P, Morandi S, et al
    Assertive outreach for "difficult to engage" patients: A useful tool for a subgroup of patients in specialized early psychosis intervention programs.
    Psychiatry Res. 2016;239:212-219.
    PubMed     Text format     Abstract available


    February 2016
  291. KOSTEN L, Verhaeghe J, Verkerk R, Thomae D, et al
    Multiprobe molecular imaging of an NMDA receptor hypofunction rat model for glutamatergic dysfunction.
    Psychiatry Res. 2016;248:1-11.
    PubMed     Text format     Abstract available


  292. LAKO IM, Taxis K, van den Heuvel ER, Leenaars CH, et al
    Altered emotional experiences attributed to antipsychotic medications - A potential link with estimated dopamine D2 receptor occupancy.
    Psychiatry Res. 2016;236:9-14.
    PubMed     Text format     Abstract available


  293. RICH AM, Cho YT, Tang Y, Savic A, et al
    Amygdala volume is reduced in early course schizophrenia.
    Psychiatry Res. 2016;250:50-60.
    PubMed     Text format     Abstract available


    January 2016
  294. VAN DONGEN JD, Buck NM, van Marle HJ
    Positive symptoms, substance use, and psychopathic traits as predictors of aggression in persons with a schizophrenia disorder.
    Psychiatry Res. 2016 Jan 28. pii: S0165-1781(16)30156.
    PubMed     Text format     Abstract available


  295. DUNCAN MJ, Faulkner G, Remington G, Arbour-Nicitopoulos K, et al
    Characterizing the affective responses to an acute bout of moderate-intensity exercise among outpatients with schizophrenia.
    Psychiatry Res. 2016 Jan 28. pii: S0165-1781(16)30081.
    PubMed     Text format     Abstract available


  296. MINICHINO A, Singh F, Pineda J, Friederich E, et al
    Biological Motion induced mu suppression is reduced in Early Psychosis (EP) patients with active negative symptoms and Autism Spectrum Disorders (ASD).
    Psychiatry Res. 2016 Jan 26. pii: S0165-1781(16)30145.
    PubMed     Text format     Abstract available


  297. ZHANG Q, Li X, Parker GJ, Hong XH, et al
    Theory of mind correlates with clinical insight but not cognitive insight in patients with schizophrenia.
    Psychiatry Res. 2016 Jan 22. pii: S0165-1781(16)30118.
    PubMed     Text format     Abstract available


  298. WYSOKINSKI A, Szczepocka E
    Platelet parameters (PLT, MPV, P-LCR) in patients with schizophrenia, unipolar depression and bipolar disorder.
    Psychiatry Res. 2016 Jan 16. pii: S0165-1781(16)30085.
    PubMed     Text format     Abstract available


  299. HAJNAL A, Csabi G, Herold R, Jeges S, et al
    Minor physical anomalies are more common among the first-degree unaffected relatives of schizophrenia patients - Results with the Mehes Scale.
    Psychiatry Res. 2016 Jan 16. pii: S0165-1781(16)30090.
    PubMed     Text format     Abstract available


  300. MAKOWSKI AC, Mnich EE, Ludwig J, Daubmann A, et al
    Changes in beliefs and attitudes toward people with depression and schizophrenia - results of a public campaign in Germany.
    Psychiatry Res. 2016 Jan 15. pii: S0165-1781(16)30071.
    PubMed     Text format     Abstract available


  301. CHOUINARD VA, Pingali SM, Chouinard G, Henderson DC, et al
    Factors associated with overweight and obesity in schizophrenia, schizoaffective and bipolar disorders.
    Psychiatry Res. 2016 Jan 14. pii: S0165-1781(16)30062.
    PubMed     Text format     Abstract available


  302. OZEKI Y, Sekine M, Fujii K, Watanabe T, et al
    Phosphoserine phosphatase activity is elevated and correlates negatively with plasma d-serine concentration in patients with schizophrenia.
    Psychiatry Res. 2016 Jan 12. pii: S0165-1781(16)30018.
    PubMed     Text format     Abstract available


  303. WU BJ, Liao HY, Chen HK, Lan TH, et al
    Psychopathology, psychopharmacological properties, decision-making capacity to consent to clinical research and the willingness to participate among long-term hospitalized patients with schizophrenia.
    Psychiatry Res. 2016 Jan 12. pii: S0165-1781(16)30046.
    PubMed     Text format     Abstract available


  304. GENC A, Kalelioglu T, Karamustafalioglu N, Tasdemir A, et al
    Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia.
    Psychiatry Res. 2016 Jan 9. pii: S0165-1781(15)30106.
    PubMed     Text format     Abstract available


  305. THOMPSON A, Marwaha S, Nelson B, Wood SJ, et al
    Do affective or dissociative symptoms mediate the association between childhood sexual trauma and transition to psychosis in an ultra-high risk cohort?
    Psychiatry Res. 2016 Jan 8. pii: S0165-1781(15)30410.
    PubMed     Text format     Abstract available


  306. CAQUEO-URIZAR A, Urzua A, Jamett PR, Irarrazaval M, et al
    Objective and subjective burden in relatives of patients with schizophrenia and its influence on care relationships in Chile.
    Psychiatry Res. 2016 Jan 8. pii: S0165-1781(16)30024.
    PubMed     Text format     Abstract available


  307. TANG DY, Liu AC, Lui SS, Lam BY, et al
    Facial emotion perception impairments in schizophrenia patients with comorbid antisocial personality disorder.
    Psychiatry Res. 2016 Jan 6. pii: S0165-1781(15)30153.
    PubMed     Text format     Abstract available


  308. KAMP D, Brinkmeyer J, Agelink MW, Habakuck M, et al
    High frequency repetitive transcranial magnetic stimulation (rTMS) reduces EEG-hypofrontality in patients with schizophrenia.
    Psychiatry Res. 2016 Jan 6. pii: S0165-1781(16)30011.
    PubMed     Text format     Abstract available


  309. GONZALEZ-GIRALDO Y, Gonzalez-Reyes RE, Forero DA
    A functional variant in MIR137, a candidate gene for schizophrenia, affects Stroop test performance in young adults.
    Psychiatry Res. 2016 Jan 5. pii: S0165-1781(15)30349.
    PubMed     Text format     Abstract available


  310. AHMED AO, Murphy CF, Latoussakis V, McGovern KE, et al
    An examination of neurocognition and symptoms as predictors of post-hospital community tenure in treatment resistant schizophrenia.
    Psychiatry Res. 2016 Jan 5. pii: S0165-1781(15)30030.
    PubMed     Text format     Abstract available


  311. UHLMANN A, Fouche JP, Koen N, Meintjes EM, et al
    Fronto-temporal alterations and affect regulation in methamphetamine dependence with and without a history of psychosis.
    Psychiatry Res. 2016 Jan 4. pii: S0925-4927(16)30002.
    PubMed     Text format     Abstract available


  312. ARNOLD AE, Iaria G, Goghari VM
    Efficacy of identifying neural components in the face and emotion processing system in schizophrenia using a dynamic functional localizer.
    Psychiatry Res. 2016 Jan 4. pii: S0925-4927(16)30003.
    PubMed     Text format     Abstract available


  313. WOODWARD TS, Leong K, Sanford N, Tipper CM, et al
    Altered balance of functional brain networks in Schizophrenia.
    Psychiatry Res. 2016 Jan 4. pii: S0925-4927(16)30004.
    PubMed     Text format     Abstract available


  314. LEE SJ, Kim B, Oh D, Kim MK, et al
    White matter alterations associated with suicide in patients with schizophrenia or schizophreniform disorder.
    Psychiatry Res. 2016 Jan 4. pii: S0925-4927(16)30009.
    PubMed     Text format     Abstract available


    December 2015
  315. TAKAESU Y, Kishimoto T, Murakoshi A, Takahashi N, et al
    Factors associated with discontinuation of aripiprazole treatment after switching from other antipsychotics in patients with chronic schizophrenia: A prospective observational study.
    Psychiatry Res. 2015 Dec 23. pii: S0165-1781(15)30870.
    PubMed     Text format     Abstract available


  316. RENES RA, Vink M, van der Weiden A, Prikken M, et al
    Impaired frontal processing during agency inferences in schizophrenia.
    Psychiatry Res. 2015 Dec 23. pii: S0925-4927(15)30186.
    PubMed     Text format     Abstract available


  317. MANCHIA M, Pinna M, Carpiniello B
    Haloperidol and loss of gray matter in schizophrenia: Reconciling meta-analytical results with molecular pharmacology.
    Psychiatry Res. 2015 Dec 19. pii: S0165-1781(15)30345.
    PubMed     Text format    


  318. FINEBERG AM, Ellman LM, Schaefer CA, Maxwell SD, et al
    Fetal exposure to maternal stress and risk for schizophrenia spectrum disorders among offspring: Differential influences of fetal sex.
    Psychiatry Res. 2015 Dec 18. pii: S0165-1781(15)30836.
    PubMed     Text format     Abstract available


  319. WATANABE Y, Nunokawa A, Shibuya M, Ikeda M, et al
    Rare truncating variations and risk of schizophrenia: Whole-exome sequencing in three families with affected siblings and a three-stage follow-up study in a Japanese population.
    Psychiatry Res. 2015 Dec 11. pii: S0165-1781(15)30452.
    PubMed     Text format     Abstract available


  320. ROCHE E, Segurado R, Renwick L, McClenaghan A, et al
    Language disturbance and functioning in first episode psychosis.
    Psychiatry Res. 2015 Dec 9. pii: S0165-1781(15)30799.
    PubMed     Text format     Abstract available


  321. WATSON A, Pribadi M, Chowdari K, Clifton S, et al
    C9orf72 repeat expansions that cause frontotemporal dementia are detectable among patients with psychosis.
    Psychiatry Res. 2015 Dec 8. pii: S0165-1781(15)30794.
    PubMed     Text format     Abstract available


  322. CAO XL, Li Y, Zhong BL, Chiu HF, et al
    Current cigarette smoking in Chinese female patients with schizophrenia: A meta-analysis.
    Psychiatry Res. 2015 Dec 3. pii: S0165-1781(15)30113.
    PubMed     Text format     Abstract available


  323. AGARWAL SM, Bose A, Shivakumar V, Narayanaswamy JC, et al
    Impact of antipsychotic medication on transcranial direct current stimulation (tDCS) effects in schizophrenia patients.
    Psychiatry Res. 2015 Dec 2. pii: S0165-1781(15)30087.
    PubMed     Text format     Abstract available


    November 2015
  324. NITKA F, Richter J, Parzer P, Resch F, et al
    Health-related quality of life among adolescents: A comparison between subjects at ultra-high risk for psychosis and healthy controls.
    Psychiatry Res. 2015 Nov 30. pii: S0165-1781(15)30135.
    PubMed     Text format     Abstract available


  325. CHEN LF, Liu J, Zhang J, Lu XQ, et al
    Non-pharmacological interventions for caregivers of patients with schizophrenia: A meta-analysis.
    Psychiatry Res. 2015 Nov 27. pii: S0165-1781(15)30707.
    PubMed     Text format     Abstract available


  326. SIEGRIST K, Millier A, Amri I, Aballea S, et al
    Association between social contact frequency and negative symptoms, psychosocial functioning and quality of life in patients with schizophrenia.
    Psychiatry Res. 2015 Nov 25. pii: S0165-1781(15)30713.
    PubMed     Text format     Abstract available


  327. BUCHY L, Seidman LJ, Cadenhead KS, Cannon TD, et al
    Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis.
    Psychiatry Res. 2015 Nov 25. pii: S0165-1781(15)30166.
    PubMed     Text format     Abstract available


  328. WANG D, Zhai JX, Liu DW
    Serum folate levels in schizophrenia: A meta-analysis.
    Psychiatry Res. 2015 Nov 25. pii: S0165-1781(15)30731.
    PubMed     Text format     Abstract available


  329. NUNEZ C, Stephan-Otto C, Cuevas-Esteban J, Maria Haro J, et al
    Effects of caffeine intake and smoking on neurocognition in schizophrenia.
    Psychiatry Res. 2015 Nov 21. pii: S0165-1781(15)30679.
    PubMed     Text format     Abstract available


  330. WANG J, Wang P, Xia Z, Liu J, et al
    Lexical and sub-lexical reading skills and their correlation to clinical symptoms in young Chinese patients with schizophrenia.
    Psychiatry Res. 2015 Nov 20. pii: S0165-1781(15)30677.
    PubMed     Text format     Abstract available


  331. MALCOLM CP, Picchioni MM, Ellett L
    Intrusive prospective imagery, posttraumatic intrusions and anxiety in schizophrenia.
    Psychiatry Res. 2015 Nov 19. pii: S0165-1781(15)30696.
    PubMed     Text format     Abstract available


  332. SCHULZE-RAUSCHENBACH S, Lennertz L, Ruhrmann S, Petrovsky N, et al
    Neurocognitive functioning in parents of schizophrenia patients: Attentional and executive performance vary with genetic loading.
    Psychiatry Res. 2015 Nov 19. pii: S0165-1781(15)30699.
    PubMed     Text format     Abstract available


  333. RIGUCCI S, Santi G, Corigliano V, Imola A, et al
    White matter microstructure in ultra-high risk and first episode schizophrenia: A prospective study.
    Psychiatry Res. 2015 Nov 18. pii: S0925-4927(15)30158.
    PubMed     Text format     Abstract available


  334. FRYDECKA D, Beszlej JA, Goscimski P, Kiejna A, et al
    Profiling cognitive impairment in treatment-resistant schizophrenia patients.
    Psychiatry Res. 2015 Nov 18. pii: S0165-1781(15)30695.
    PubMed     Text format     Abstract available


  335. GRIGOROIU-SERBANESCU M, Diaconu CC, Heilmann-Heimbach S, Neagu AI, et al
    Association of age-of-onset groups with GWAS significant schizophrenia and bipolar disorder loci in Romanian bipolar I patients.
    Psychiatry Res. 2015 Nov 10. pii: S0165-1781(15)30052.
    PubMed     Text format     Abstract available


  336. NYKANEN S, Puska V, Tolonen JP, Salo H, et al
    Use of psychiatric medications in schizophrenia and other psychoses in a general population sample.
    Psychiatry Res. 2015 Nov 10. pii: S0165-1781(15)30654.
    PubMed     Text format     Abstract available


  337. HWANG SS, Ahn YM, Kim YS
    Neurocognitive functioning as an intermediary variable between psychopathology and insight in schizophrenia.
    Psychiatry Res. 2015 Nov 9. pii: S0165-1781(15)30618.
    PubMed     Text format     Abstract available


  338. PHALEN PL, Viswanadhan K, Lysaker PH, Warman DM, et al
    The relationship between cognitive insight and quality of life in schizophrenia spectrum disorders: Symptom severity as potential moderator.
    Psychiatry Res. 2015 Nov 6. pii: S0165-1781(15)30060.
    PubMed     Text format     Abstract available


  339. NELSON BD, Bjorkquist OA, Olsen EK, Herbener ES, et al
    Schizophrenia symptom and functional correlates of anterior cingulate cortex activation to emotion stimuli: An fMRI investigation.
    Psychiatry Res. 2015 Nov 6. pii: S0925-4927(15)30098.
    PubMed     Text format     Abstract available


  340. DEAN OM, Mancuso SG, Bush AI, Copolov D, et al
    Benefits of adjunctive N-acetylcysteine in a sub-group of clozapine-treated individuals diagnosed with schizophrenia.
    Psychiatry Res. 2015 Nov 2. pii: S0165-1781(15)30605.
    PubMed     Text format    


    October 2015
  341. ANDERSON VM, McIlwain ME, Kydd RR, Russell BR, et al
    Does cognitive impairment in treatment-resistant and ultra-treatment-resistant schizophrenia differ from that in treatment responders?
    Psychiatry Res. 2015 Oct 31. pii: S0165-1781(15)30604.
    PubMed     Text format     Abstract available


  342. VAN ERP TG, Preda A, Turner JA, Callahan S, et al
    Neuropsychological profile in adult schizophrenia measured with the CMINDS.
    Psychiatry Res. 2015 Oct 26. pii: S0165-1781(15)30569.
    PubMed     Text format     Abstract available


    September 2015
  343. VASKINN A, Hartberg CB, Sundet K, Westlye LT, et al
    To the editors: Reply to Anna R. Docherty.
    Psychiatry Res. 2015;233:497.
    PubMed     Text format    


    August 2015
  344. DOCKERY L, Jeffery D, Schauman O, Williams P, et al
    Stigma- and non-stigma-related treatment barriers to mental healthcare reported by service users and caregivers.
    Psychiatry Res. 2015;228:612-9.
    PubMed     Text format     Abstract available


  345. VAN HEUGTEN-VAN DER KLOET D, Giesbrecht T, van Wel J, Bosker WM, et al
    MDMA, cannabis, and cocaine produce acute dissociative symptoms.
    Psychiatry Res. 2015;228:907-12.
    PubMed     Text format     Abstract available


    July 2015
  346. KOELKEBECK K, Kohl W, Luettgenau J, Triantafillou S, et al
    Benefits of using culturally unfamiliar stimuli in ambiguous emotion identification: A cross-cultural study.
    Psychiatry Res. 2015;228:39-45.
    PubMed     Text format     Abstract available


  347. ROCHE MW, Fowler ML, Lenzenweger MF
    Deeper into schizotypy and motor performance: Investigating the nature of motor control in a non-psychiatric sample.
    Psychiatry Res. 2015;228:20-5.
    PubMed     Text format     Abstract available


    June 2015
  348. O'CONNOR K, Nelson B, Lin A, Wood SJ, et al
    Are UHR patients who present with hallucinations alone at lower risk of transition to psychosis?
    Psychiatry Res. 2015 Jun 29. pii: S0165-1781(15)00398.
    PubMed     Text format     Abstract available


    April 2015
  349. DENG Y, Goodrich-Hunsaker NJ, Cabaral M, Amaral DG, et al
    Disrupted fornix integrity in children with chromosome 22q11.2 deletion syndrome.
    Psychiatry Res. 2015;232:106-14.
    PubMed     Text format     Abstract available


  350. OTA M, Ogawa S, Kato K, Wakabayashi C, et al
    Methamphetamine-sensitized rats show augmented dopamine release to methylphenidate stimulation: a positron emission tomography using [18F]fallypride.
    Psychiatry Res. 2015;232:92-7.
    PubMed     Text format     Abstract available


    March 2015
  351. ZIK JB, Roberts DL
    The many faces of oxytocin: implications for psychiatry.
    Psychiatry Res. 2015;226:31-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: